Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2026-01-29
Summary
This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.
Conditions
Sponsors & Collaborators
-
Taichung Veterans General Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-20
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
NCT03829852 ·Status: COMPLETED
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy
NCT06980350 ·Status: COMPLETED
-
Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
NCT06215677 ·Status: RECRUITING ·Phase: NA
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
Application of MR-PET in Colorectal Cancer
NCT02553031 ·Status: UNKNOWN
-
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
NCT04466254 ·Status: UNKNOWN ·Phase: PHASE2
-
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
NCT05962502 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer
NCT05676190 ·Status: RECRUITING ·Phase: NA
-
A Translational Study for Locoregional Recurrence of T4 Colon Cancer
NCT06958926 ·Status: RECRUITING
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 ·Status: COMPLETED
-
Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission
NCT05964530 ·Status: RECRUITING ·Phase: NA
-
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan.
NCT05731336 ·Status: RECRUITING
-
Study on the Applicability of CCR Criteria in Rectal Cancer
NCT06794099 ·Status: COMPLETED
-
DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer
NCT02415699 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296 ·Status: UNKNOWN
-
Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer
NCT07012174 ·Status: COMPLETED
-
Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer
NCT06718738 ·Status: RECRUITING ·Phase: PHASE1
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Establishment of Individualized Immunotherapy Strategy and Platform Based on Changes of Intestinal Microbiota
NCT05065515 ·Status: UNKNOWN
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN